| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cerevel Therapeutics Holdings, Inc. | Director | Common Stock | 0 | $0 | $41.18 | 01 Aug 2024 | Direct |
| Cerevel Therapeutics Holdings, Inc. | Director | Stock Option (Right to Buy) | 0 | 01 Aug 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CERE | Cerevel Therapeutics Holdings, Inc. | 01 Aug 2024 | 3 | $0 | 4 | Director | 05 Aug 2024, 16:36 |
| CERE | Cerevel Therapeutics Holdings, Inc. | 05 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 16:30 |
| CERE | Cerevel Therapeutics Holdings, Inc. | 07 Jun 2023 | 2 | $0 | 4 | Director | 09 Jun 2023, 16:15 |
| CERE | Cerevel Therapeutics Holdings, Inc. | 14 Jun 2022 | 1 | $0 | 4 | Director | 16 Jun 2022, 16:46 |
| CERE | Cerevel Therapeutics Holdings, Inc. | 10 Jun 2021 | 1 | $0 | 4 | Director | 14 Jun 2021, 20:04 |